BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 1346796)

  • 1. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
    Robertson MJ; Soiffer RJ; Wolf SF; Manley TJ; Donahue C; Young D; Herrmann SH; Ritz J
    J Exp Med; 1992 Mar; 175(3):779-88. PubMed ID: 1346796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation.
    Valiante NM; Rengaraju M; Trinchieri G
    Cell Immunol; 1992 Nov; 145(1):187-98. PubMed ID: 1358460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
    D'Andrea A; Rengaraju M; Valiante NM; Chehimi J; Kubin M; Aste M; Chan SH; Kobayashi M; Young D; Nickbarg E
    J Exp Med; 1992 Nov; 176(5):1387-98. PubMed ID: 1357073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
    Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
    J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
    Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
    Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
    Baume DM; Robertson MJ; Levine H; Manley TJ; Schow PW; Ritz J
    Eur J Immunol; 1992 Jan; 22(1):1-6. PubMed ID: 1370410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
    Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
    J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines.
    Lieberman MD; Sigal RK; Williams NN; Daly JM
    J Surg Res; 1991 Apr; 50(4):410-5. PubMed ID: 1673486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
    D'Andrea A; Aste-Amezaga M; Valiante NM; Ma X; Kubin M; Trinchieri G
    J Exp Med; 1993 Sep; 178(3):1041-8. PubMed ID: 8102388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis.
    Bellone G; Trinchieri G
    J Immunol; 1994 Aug; 153(3):930-7. PubMed ID: 7517976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
    Chan SH; Perussia B; Gupta JW; Kobayashi M; PospĂ­sil M; Young HA; Wolf SF; Young D; Clark SC; Trinchieri G
    J Exp Med; 1991 Apr; 173(4):869-79. PubMed ID: 1672545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
    Kobayashi M; Fitz L; Ryan M; Hewick RM; Clark SC; Chan S; Loudon R; Sherman F; Perussia B; Trinchieri G
    J Exp Med; 1989 Sep; 170(3):827-45. PubMed ID: 2504877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.
    Trinchieri G; Wysocka M; D'Andrea A; Rengaraju M; Aste-Amezaga M; Kubin M; Valiante NM; Chehimi J
    Prog Growth Factor Res; 1992; 4(4):355-68. PubMed ID: 1364096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
    Dadmarz R; Bockstoce DC; Golub SH
    Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction mechanism of human blood CD8+ T cell proliferation and cytotoxicity by natural killer cell stimulatory factor (interleukin-12).
    Nabioullin R; Sone S; Nii A; Haku T; Ogura T
    Jpn J Cancer Res; 1994 Aug; 85(8):853-61. PubMed ID: 7928632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2.
    Chan SH; Kobayashi M; Santoli D; Perussia B; Trinchieri G
    J Immunol; 1992 Jan; 148(1):92-8. PubMed ID: 1345792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.
    Wolf SF; Temple PA; Kobayashi M; Young D; Dicig M; Lowe L; Dzialo R; Fitz L; Ferenz C; Hewick RM
    J Immunol; 1991 May; 146(9):3074-81. PubMed ID: 1673147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.
    Caligiuri MA; Murray C; Robertson MJ; Wang E; Cochran K; Cameron C; Schow P; Ross ME; Klumpp TR; Soiffer RJ
    J Clin Invest; 1993 Jan; 91(1):123-32. PubMed ID: 7678599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
    Robertson MJ; Caligiuri MA; Manley TJ; Levine H; Ritz J
    J Immunol; 1990 Nov; 145(10):3194-201. PubMed ID: 1700001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.